News PharmaCielo Ltd.

Equities

PCLO

CA71716K1012

Delayed Toronto S.E. Other stock markets 10:29:07 2024-05-07 am EDT			5-day change	1st Jan Change
0.155 ^CAD	-3.13%		-.--%	-13.89%

Apr. 10	PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding	CI
Jan. 04	Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Canadian Investment Regulatory Organization Trading Halt - PCLO	May. 08	AQ
PharmaCielo Announces Issuance of Failure to File Cease Trade Order	May. 08	NE
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors	Apr. 10	NE
PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding	Apr. 09	CI
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil	Mar. 26	NE
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo	Mar. 01	NE
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	Jan. 04	CI
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	Jan. 04	NE
PharmaCielo Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29	CI
PharmaCielo Announces Q3 2023 Financial Results	Nov. 29	NE
PharmaCielo Raises $3.3 Million Under Non-Brokered Private Placement	23-10-06	MT
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement	23-10-06	NE
PharmaCielo Ltd. announced that it has received CAD 4.78 million in funding	23-10-05	CI
PharmaCielo Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Pharmacielo Ltd. Appoints Marc Lustig as CEO	23-07-11	CI
Pharmacielo Ltd. Announces Board Changes	23-07-11	CI
PharmaCielo Ltd. announced that it expects to receive CAD 5 million in funding	23-06-28	CI
PharmaCielo Ltd. announced that it has received CAD 12.825 million in funding	23-06-28	CI
PharmaCielo Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
PharmaCielo Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PharmaCielo Ltd.

Equities

PCLO

CA71716K1012

Summary

Filters